GILEAD SCIENCES INC Insider Trading for June 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GILEAD SCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in GILEAD SCIENCES INC for June 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30 2015 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 20.71 | 15,000 | 310,575 | 90,000 | |
| Jun 30 2015 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 14.34 | 12,000 | 172,080 | 0 | |
| Jun 30 2015 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 120.13 | 27,000 | 3,243,421 | 44,309 | 71.3 K to 44.3 K (-37.86 %) |
| Jun 30 2015 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | M | 20.71 | 15,000 | 310,575 | 71,309 | 86.3 K to 71.3 K (-17.38 %) |
| Jun 30 2015 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 14.34 | 12,000 | 172,080 | 56,309 | 44.3 K to 56.3 K (+27.08 %) |
| Jun 22 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 26.99 | 10,000 | 269,900 | 12,687 | |
| Jun 22 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 120.00 | 10,000 | 1,200,025 | 47,632 | 57.6 K to 47.6 K (-17.35 %) |
| Jun 22 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 26.99 | 10,000 | 269,900 | 57,632 | 47.6 K to 57.6 K (+20.99 %) |
| Jun 17 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 21.58 | 70,000 | 1,510,250 | 120,000 | |
| Jun 17 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 117.99 | 48,163 | 5,682,497 | 165,168 | 213.3 K to 165.2 K (-22.58 %) |
| Jun 17 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 116.98 | 21,837 | 2,554,505 | 213,331 | 235.2 K to 213.3 K (-9.29 %) |
| Jun 17 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 21.58 | 70,000 | 1,510,250 | 235,168 | 165.2 K to 235.2 K (+42.38 %) |
| Jun 10 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Option Exercise | M | 14.50 | 100,000 | 1,450,250 | 600,000 | |
| Jun 10 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 114.65 | 4,250 | 487,280 | 1,029,108 | 1 M to 1 M (-0.41 %) |
| Jun 10 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 114.03 | 95,750 | 10,918,133 | 1,033,358 | 1.1 M to 1 M (-8.48 %) |
| Jun 10 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Buy | M | 14.50 | 100,000 | 1,450,250 | 1,129,108 | 1 M to 1.1 M (+9.72 %) |
| Jun 03 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 14.50 | 150,000 | 2,175,375 | 900,000 | |
| Jun 03 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 114.25 | 103,200 | 11,790,714 | 4,255,876 | 4.4 M to 4.3 M (-2.37 %) |
| Jun 03 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 113.28 | 46,800 | 5,301,630 | 4,359,076 | 4.4 M to 4.4 M (-1.06 %) |
| Jun 03 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 14.50 | 150,000 | 2,175,375 | 4,405,876 | 4.3 M to 4.4 M (+3.52 %) |
| Jun 03 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Option Exercise | M | 23.76 | 10,625 | 252,397 | 31,375 | |
| Jun 03 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Option Exercise | M | 23.60 | 4,375 | 103,250 | 0 | |
| Jun 03 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 114.36 | 1,000 | 114,364 | 141,422 | 142.4 K to 141.4 K (-0.70 %) |
| Jun 03 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 113.35 | 1,000 | 113,354 | 142,422 | 143.4 K to 142.4 K (-0.70 %) |
| Jun 03 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 114.31 | 6,044 | 690,867 | 143,422 | 149.5 K to 143.4 K (-4.04 %) |
| Jun 03 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 113.14 | 8,956 | 1,013,305 | 149,466 | 158.4 K to 149.5 K (-5.65 %) |
| Jun 03 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Buy | M | 23.76 | 10,625 | 252,397 | 158,422 | 147.8 K to 158.4 K (+7.19 %) |
| Jun 03 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Buy | M | 23.60 | 4,375 | 103,250 | 147,797 | 143.4 K to 147.8 K (+3.05 %) |
| Jun 03 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 40.56 | 1,706 | 69,195 | 13,891 | |
| Jun 03 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 26.99 | 1,294 | 34,925 | 22,687 | |
| Jun 03 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 113.09 | 3,000 | 339,278 | 47,632 | 50.6 K to 47.6 K (-5.93 %) |
| Jun 03 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 26.99 | 1,294 | 34,925 | 50,632 | 49.3 K to 50.6 K (+2.62 %) |
| Jun 03 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 40.56 | 1,706 | 69,195 | 49,338 | 47.6 K to 49.3 K (+3.58 %) |
| Jun 03 2015 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Gift | G | 0.00 | 925 | 0 | 100,546 | 101.5 K to 100.5 K (-0.91 %) |